These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24595456)

  • 1. Natural compounds' activity against cancer stem-like or fast-cycling melanoma cells.
    Sztiller-Sikorska M; Koprowska K; Majchrzak K; Hartman M; Czyz M
    PLoS One; 2014; 9(3):e90783. PubMed ID: 24595456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres.
    Czyz M; Koprowska K; Sztiller-Sikorska M
    Cancer Biol Ther; 2013 Feb; 14(2):135-45. PubMed ID: 23192276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-proliferative and pro-apoptotic activity of glycosidic derivatives of lawsone in melanoma cancer cell.
    de Franca MNF; Isidório RG; Bonifacio JHO; Dos Santos EWP; Santos JF; Ottoni FM; de Lucca Junior W; Scher R; Alves RJ; Corrêa CB
    BMC Cancer; 2021 Jun; 21(1):662. PubMed ID: 34078316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCB5 is activated by MITF and β-catenin and is associated with melanoma differentiation.
    Louphrasitthiphol P; Chauhan J; Goding CR
    Pigment Cell Melanoma Res; 2020 Jan; 33(1):112-118. PubMed ID: 31595650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphere formation and self-renewal capacity of melanoma cells is affected by the microenvironment.
    Sztiller-Sikorska M; Koprowska K; Jakubowska J; Zalesna I; Stasiak M; Duechler M; Czyz ME
    Melanoma Res; 2012 Jun; 22(3):215-24. PubMed ID: 22495670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic diversity of patient-derived melanoma populations in stem cell medium.
    Sztiller-Sikorska M; Hartman ML; Talar B; Jakubowska J; Zalesna I; Czyz M
    Lab Invest; 2015 Jun; 95(6):672-83. PubMed ID: 25867763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
    Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
    Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PI3K/AKT signaling pathway controls the quiescence of the low-Rhodamine123-retention cell compartment enriched for melanoma stem cell activity.
    Touil Y; Zuliani T; Wolowczuk I; Kuranda K; Prochazkova J; Andrieux J; Le Roy H; Mortier L; Vandomme J; Jouy N; Masselot B; Ségard P; Quesnel B; Formstecher P; Polakowska R
    Stem Cells; 2013 Apr; 31(4):641-51. PubMed ID: 23355370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parthenolide enhances dacarbazine activity against melanoma cells.
    Koprowska K; Hartman ML; Sztiller-Sikorska M; Czyz ME
    Anticancer Drugs; 2013 Sep; 24(8):835-45. PubMed ID: 23797801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Slow Cycling Phenotype: A Growing Problem for Treatment Resistance in Melanoma.
    Ahn A; Chatterjee A; Eccles MR
    Mol Cancer Ther; 2017 Jun; 16(6):1002-1009. PubMed ID: 28576947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
    Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
    Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Products and Cancer Stem Cells.
    Marucci C; Fumagalli G; Calogero F; Silvani A; Christodoulou MS; Martinet N; Passarella D
    Curr Pharm Des; 2015; 21(38):5547-57. PubMed ID: 26429713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells.
    Shidal C; Al-Rayyan N; Yaddanapudi K; Davis KR
    Oncotarget; 2016 Dec; 7(51):84128-84141. PubMed ID: 27566591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
    Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
    Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance.
    Ahmed F; Haass NK
    Front Oncol; 2018; 8():173. PubMed ID: 29881716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of microphthalmia-associated transcription factor, but not NF-kappa B sensitizes melanoma specific cell death.
    Mokhamatam RB; Sahoo BK; Manna SK
    Apoptosis; 2016 Aug; 21(8):928-40. PubMed ID: 27325430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133⁺ melanoma subpopulation acquired resistance to caffeic acid phenethyl ester-induced apoptosis is attributed to the elevated expression of ABCB5: significance for melanoma treatment.
    El-Khattouti A; Sheehan NT; Monico J; Drummond HA; Haikel Y; Brodell RT; Megahed M; Hassan M
    Cancer Lett; 2015 Feb; 357(1):83-104. PubMed ID: 25449786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma.
    Tornin J; Martinez-Cruzado L; Santos L; Rodriguez A; Núñez LE; Oro P; Hermosilla MA; Allonca E; Fernández-García MT; Astudillo A; Suarez C; Morís F; Rodriguez R
    Oncotarget; 2016 May; 7(21):30935-50. PubMed ID: 27105533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy.
    Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F
    Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cells initiating human melanomas.
    Schatton T; Murphy GF; Frank NY; Yamaura K; Waaga-Gasser AM; Gasser M; Zhan Q; Jordan S; Duncan LM; Weishaupt C; Fuhlbrigge RC; Kupper TS; Sayegh MH; Frank MH
    Nature; 2008 Jan; 451(7176):345-9. PubMed ID: 18202660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.